Iluvien (Fluocinolone Acetonide Implant)
ILUVIEN is an FDA approved injectable intravitreal implant of fluocinolone acetonide and is the first diabetic macular edema (DME) treatment to deliver 36 months of continuous, low-dose corticosteroid with a single injection. Steroids may play an important role in addressing the inflammatory process associated with DME.